Immucell (ICCC) Return on Equity [ROE] (2011 - 2026)
Immucell (ICCC) recorded Return on Equity [ROE] of -2.23% in Q2 2026, down 8.22 percentage points from 5.99% a year earlier.
Powered by 
Analysis
Immucell (ICCC) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Immucell reported Return on Equity [ROE] of -3.81%, up 4.40 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -0.24 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -8.21% in FY2024 (+12.64 pp), -20.86% in FY2023 (-12.93 pp), -7.92% in FY2022 (-7.66 pp) and -0.26% in FY2021 (+3.31 pp).
- Quarterly Return on Equity [ROE] has ranged from -23.84% in Q3 2023 to 7.79% in Q3 2025 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] rose in six of the last seven quarters, with an average year-over-year change of +11.42 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 23.07 percentage points in Q3 2025, against a drop of 24.75 percentage points in Q1 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 4.97% |
| 10 | Immucell | 92.91 Mn | 70.36 Mn | 2.44 Mn | -2.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.23% |
| Dec 31, 2025 | -3.66% |
| Sep 30, 2025 | 7.79% |
| Jun 30, 2025 | 5.99% |
| Mar 31, 2025 | -0.96% |
| Dec 31, 2024 | -8.00% |
| Sep 30, 2024 | -15.28% |
| Jun 30, 2024 | -16.84% |
| Mar 31, 2024 | -15.71% |
| Dec 31, 2023 | -22.64% |
| Sep 30, 2023 | -23.84% |
| Jun 30, 2023 | -21.88% |
| Mar 31, 2023 | -20.52% |
| Dec 31, 2022 | -8.55% |
| Sep 30, 2022 | -2.86% |
| Jun 30, 2022 | -0.36% |
| Mar 31, 2022 | 4.23% |
| Dec 31, 2021 | -0.24% |
| Sep 30, 2021 | 0.11% |
| Jun 30, 2021 | -1.44% |
API Access
Immucell Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();